RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinomas (PDAC) belong to the most frequent and most deadly malignancies in the western world. Mutations in KRAS and TP53 along with some other frequent polymorphisms occur almost universally and are likely to be responsible for tumor initiation. However, these mutations can...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaß, Markus, Michl, Patrick, Hüttelmaier, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312628/
https://www.ncbi.nlm.nih.gov/pubmed/32545414
http://dx.doi.org/10.3390/ijms21114190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312628/
https://www.ncbi.nlm.nih.gov/pubmed/32545414
http://dx.doi.org/10.3390/ijms21114190

Ejemplares similares